Your Search for 'Comparisons of Pharmaceutical Manufacturing between China and India' returned 12 results - Page 1 of 1

• Outlook of China Drug Formulation Market

  EURO€ 2,525.00USD$ 3,285.00GBP£ 2,124.00AUD$ 3,213.00JPY¥ 324,338.00SEK 21 569,00CHF 3'096.00CAD$ 3,347.00 JZMed Inc, May 2011 , Pages: 230
  comparisons of pharmaceutical industry between China and India 3.2.1 Comparison of development history of pharmaceutical industry in China and India 3.2.2 Comparison of pharmaceutical markets between China and ...

• Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China

  EURO€ 2,305.00USD$ 2,999.00GBP£ 1,939.00AUD$ 2,933.00JPY¥ 296,100.00SEK 19 691,00CHF 2'827.00CAD$ 3,056.00 JZMed Inc, Mar 2008 , Pages: 180
  . - Detailed comparisons between the Indian pharmaceutical outsourcing service industry and the Chinese pharmaceutical outsourcing service industry, including the strengths and weakness of each country in each ...

• Comparison of Biopharmaceutical Industry between China and India 2013

  EURO€ 3,294.00USD$ 4,285.00GBP£ 2,771.00AUD$ 4,191.00JPY¥ 423,071.00SEK 28 135,00CHF 4'039.00CAD$ 4,366.00 JZMed Inc, Mar 2013 , Pages: 215
  . The report, “Comparison of Biopharmaceutical Industry between China and India”, published by JZMed, Inc, a world renowned market research firm specialized in pharmaceutical and biotechnology industries ...

• The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology

  EURO€ 3,071.00USD$ 3,995.00GBP£ 2,584.00AUD$ 3,907.00JPY¥ 394,438.00SEK 26 231,00CHF 3'765.00CAD$ 4,071.00 JZMed Inc, Oct 2011 , Pages: 215
  small molecule drugs f. Contract manufacturing of biologic drugs 4.4.2 New development trends of pharma outsourcing in India 1. Comparison of pharma outsourcing between China and India 2. Activities of ...

• Chinese Biopharmaceutical Industry: Current State and Future

  EURO€ 2,225.00USD$ 2,895.00GBP£ 1,872.00AUD$ 2,832.00JPY¥ 285,832.00SEK 19 008,00CHF 2'729.00CAD$ 2,950.00 JZMed Inc, Aug 2010 , Pages: 299
  comparisons with their Western as well as Indian counterparts, the report also analyzed in depth where the current R&D and manufacturing capability of the Chinese biopharma industry stands in the global ...

• The New Trend of API Sourcing and Contract Manufacturing in China

  EURO€ 1,526.00USD$ 1,985.00GBP£ 1,284.00AUD$ 1,941.00JPY¥ 195,985.00SEK 13 033,00CHF 1'871.00CAD$ 2,023.00 JZMed Inc, Feb 2010 , Pages: 158
  development history of global CMO industry Table 12. Comparisons of CMO market sizes between China and India (2007-2009) Table 13. Current market value and growth history of Chinese API industry Table 14 ...

• State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma

  EURO€ 3,536.00USD$ 4,600.00GBP£ 2,975.00AUD$ 4,499.00JPY¥ 454,172.00SEK 30 203,00CHF 4'336.00CAD$ 4,687.00 Decision Resources, Inc, Jan 2010 , Pages: 46
  . - Generic pharmaceutical companies: Major generics companies, relative size based on worldwide sales, Big Pharma’s new affi nity for generics, nature of the relationship between Big Pharma and generics ...

• Opportunities in Emerging Markets - Newly Industrialized Asia (South Korea, Singapore, Taiwan, and Hong Kong SAR)

  EURO€ 3,536.00USD$ 4,600.00GBP£ 2,975.00AUD$ 4,499.00JPY¥ 454,172.00SEK 30 203,00CHF 4'336.00CAD$ 4,687.00 Decision Resources, Inc, Apr 2011 , Pages: 41
  , Russia, India, China, Mexico, Turkey (BRIC-MT); newly industrialized Asian economies (NIEs), including Singapore, Taiwan (Province of China), Hong Kong Special Administrative Region (SAR), and Republic of ...

• Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index

  EURO€ 2,305.00USD$ 2,999.00GBP£ 1,939.00AUD$ 2,933.00JPY¥ 296,100.00SEK 19 691,00CHF 2'827.00CAD$ 3,056.00 Arrowhead Publishers, May 2007 , Pages: 215
  Trials in China (in US$) Table 5.1 Urban India – Population Table 5.2 The Cost of Clinical Trials in India vs. the US Table 5.3 Top Pharmaceutical Companies’ R&D and Manufacturing Offshoring Activities ...

• Understanding City and Regional Health Markets in Brazil, Russia, India and China

  EURO€ 1,728.00USD$ 2,248.00GBP£ 1,454.00AUD$ 2,199.00JPY¥ 221,959.00SEK 14 761,00CHF 2'119.00CAD$ 2,291.00 Espicom Business Intelligence Ltd, Sep 2012
  with countries such as India and China, there is a yawning gap between well-provided for cities, and the more remote regions. In 2010, the government introduced the idea of a regional healthcare services ...

• Growth Strategies In Generics: Innovative And Aggressive Strategies And Their Impact On Branded Pharmaceuticals

  EURO€ 2,210.00USD$ 2,875.00GBP£ 1,859.00AUD$ 2,812.00JPY¥ 283,857.00SEK 18 877,00CHF 2'710.00CAD$ 2,930.00 Scripp Business Insights, Jul 2004 , Pages: 172
  , India, Eastern Europe and Latin America. "A review of the portfolios of the top 40 pharmaceutical companies shows that products with total sales of $137 billion in 2002 will have lost primary US patent ...

• The European Generics Outlook: A Country-By-Country Analysis Of Developing Market Opportunities And Revenue Defense Strategies

  EURO€ 2,210.00USD$ 2,875.00GBP£ 1,859.00AUD$ 2,812.00JPY¥ 283,857.00SEK 18 877,00CHF 2'710.00CAD$ 2,930.00 Scripp Business Insights, Apr 2003 , Pages: 190
  ? 169 Factors boosting Indian companies 169 International expansion 170 China 170 Impact of political factors 170 Sourcing formulations and APIs 171 Turkey 172 The bridge between East and West? 172 ...